Stay updated on Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded: Revision: v3.4.2. Removed: Notice about government funding and operating status. These are maintenance updates to the ClinicalTrials.gov site and do not affect study data or user actions.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding and an updated revision tag (v3.4.1). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdministrative UI and metadata updates were made (glossary toggle, QC-related labels, FEAR Act wording, and a new version revision). These changes do not affect the study content, eligibility criteria, or trial results.SummaryDifference0.3%

- Check35 days agoChange DetectedKey sections such as sponsor/investigators, study locations, eligibility criteria, and primary outcomes appear removed or collapsed. The page's detailed trial information is notably reduced, affecting how a user would assess participation and reach the study team.SummaryDifference15%

- Check42 days agoChange DetectedThe page shows a new Revision: v3.3.4 and removal of v3.3.3; no changes to core study data or human subjects details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA dedicated Locations section was added listing North Carolina as a participating site. The page revision updates from v3.3.2 to v3.3.3 and removes the previous North Carolina location entry along with the HHS Vulnerability Disclosure link.SummaryDifference0.3%

Stay in the know with updates to Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Q301 Safety and Efficacy in Atopic Dermatitis Clinical Trial page.